2432.40 -6.80 (-0.28%)

27.95% Gain from 52W Low

230.6K NSE+BSE Volume

NSE 23 May, 2025 3:31 PM (IST)

Margin Decline
Mankind Pharma's Q4FY25 net profit declines 10.7% YoY, EBITDA margin contracts 200 bps YoY to 22.2% See details

Mankind Pharma Ltd. Annual Results